[go: up one dir, main page]

MX2008009705A - Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo. - Google Patents

Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo.

Info

Publication number
MX2008009705A
MX2008009705A MX2008009705A MX2008009705A MX2008009705A MX 2008009705 A MX2008009705 A MX 2008009705A MX 2008009705 A MX2008009705 A MX 2008009705A MX 2008009705 A MX2008009705 A MX 2008009705A MX 2008009705 A MX2008009705 A MX 2008009705A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
compositions containing
obtaining
degradation inhibitor
same
Prior art date
Application number
MX2008009705A
Other languages
English (en)
Inventor
Antonio Machado
Aurelio Maranduba
Eneida Guimaraes
Livia Machado
Marcio Junior Santiago
Maria Silva
Original Assignee
Quiral Quimica Do Brasil S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quiral Quimica Do Brasil S A filed Critical Quiral Quimica Do Brasil S A
Publication of MX2008009705A publication Critical patent/MX2008009705A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las composiciones farmacéuticas que contienen polisorbato 80, docetaxel anhidro (I) o su trihidrato y un ácido orgánico con un pKa entre 2.5-4.5 utilizado como un inhibidor de degradación. Las composiciones obtenidas de esta manera son estériles y estables hasta por 30 meses cuando se almacenan a temperatura ambiente, que corresponde a un rango entre 15 y 30ºC, ( 1ºC, y presentan niveles bajos de 7-epi-docexatel (II).
MX2008009705A 2006-01-30 2006-02-09 Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo. MX2008009705A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0600194-7A BRPI0600194A (pt) 2006-01-30 2006-01-30 composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
PCT/BR2006/000016 WO2007085067A1 (en) 2006-01-30 2006-02-09 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same.

Publications (1)

Publication Number Publication Date
MX2008009705A true MX2008009705A (es) 2008-10-08

Family

ID=38603030

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008009705A MX2008009705A (es) 2006-01-30 2006-02-09 Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo.

Country Status (9)

Country Link
US (1) US20090221688A1 (es)
EP (1) EP1978953A1 (es)
JP (1) JP2009524700A (es)
CN (1) CN101415416A (es)
BR (1) BRPI0600194A (es)
CA (1) CA2640950A1 (es)
MX (1) MX2008009705A (es)
RU (1) RU2408362C2 (es)
WO (1) WO2007085067A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
BRPI0600194A (pt) 2006-01-30 2007-10-23 Quiral Quimica Do Brasil S A composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
KR100878455B1 (ko) * 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
CN101396354B (zh) * 2007-09-30 2010-12-01 江苏恒瑞医药股份有限公司 一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
KR101053780B1 (ko) * 2008-02-29 2011-08-02 동아제약주식회사 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
CN101708177B (zh) * 2009-11-23 2012-09-05 浙江万马药业有限公司 一种含多西他赛的药物组合物及其制备方法
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
US8722900B2 (en) 2011-10-31 2014-05-13 Scinopharm Taiwan, Ltd. Process for cabazitaxel, and intermediates thereof
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
JP2013194009A (ja) * 2012-03-21 2013-09-30 Nipro Corp ドセタキセル製剤
ES2687705T3 (es) * 2012-07-19 2018-10-26 Fujifilm Corporation Composición líquida que contiene un principio activo a base de taxano, proceso de producción de la misma y preparación medicinal líquida
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
EP2777691A1 (en) * 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EA024176B1 (ru) * 2014-03-05 2016-08-31 Республиканское Унитарное Производственное Предприятие "Белмедпрепараты" (Руп "Белмедпрепараты") Способ получения противоопухолевого препарата на основе доцетаксела
TWI715636B (zh) 2015-09-30 2021-01-11 香港商慧源香港創新有限公司 口服紫杉烷組合物及方法
JP6292267B2 (ja) * 2016-09-13 2018-03-14 ニプロ株式会社 ドセタキセル製剤
JP2018115178A (ja) * 2018-03-15 2018-07-26 ニプロ株式会社 ドセタキセル製剤
CN111557934A (zh) * 2020-06-10 2020-08-21 四川汇宇制药股份有限公司 一种含多西他赛的药物组合物及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
DK0835657T3 (da) * 1992-11-27 2005-01-10 Mayne Pharma Usa Inc Stabil, injicerbar paclitaxelsammensætning
FR2698543B1 (fr) 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
EP0876145A4 (en) * 1995-12-21 1999-04-21 Genelabs Tech Inc TAX COMPOSITION AND PROCEDURE
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
KR20030019327A (ko) * 2000-03-24 2003-03-06 아이박스 리서치 인코포레이티드 탁산-기저 조성물을 안정시키는 금속염의 용도
EP1374864A1 (en) * 2002-06-26 2004-01-02 Munich Biotech AG Amphiphilic taxane compositions
CN1241561C (zh) * 2002-12-16 2006-02-15 天津大学 紫杉烷类的注射药制剂
US20040171560A1 (en) * 2002-12-23 2004-09-02 Dabur Research Foundation Stabilized pharmaceutical composition
EP1510206A1 (en) * 2003-08-29 2005-03-02 Novagali Pharma SA Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
WO2005061474A1 (en) * 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
US20090065745A1 (en) 2005-03-31 2009-03-12 Hirotsugu Kido Anti-degradation agent
EP2308467A3 (en) 2005-06-17 2011-06-22 Hospira Australia Pty Ltd Liquid pharmaceutical formulations of docetaxel
US8034765B2 (en) 2005-08-31 2011-10-11 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
CN100408032C (zh) 2006-01-18 2008-08-06 深圳万乐药业有限公司 一种稳定的多西他赛注射剂
BRPI0600194A (pt) 2006-01-30 2007-10-23 Quiral Quimica Do Brasil S A composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas

Also Published As

Publication number Publication date
EP1978953A1 (en) 2008-10-15
US20090221688A1 (en) 2009-09-03
WO2007085067A1 (en) 2007-08-02
CN101415416A (zh) 2009-04-22
BRPI0600194A (pt) 2007-10-23
RU2008131308A (ru) 2010-03-10
RU2408362C2 (ru) 2011-01-10
CA2640950A1 (en) 2007-08-02
JP2009524700A (ja) 2009-07-02

Similar Documents

Publication Publication Date Title
MX2008009705A (es) Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo.
WO2008131860A3 (de) Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung und deren verwendung
MY138708A (en) Biaryloxymethylarenecarboxylic acids
MY149622A (en) Pyrazoles as 11-beta-hsd-1
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
MX2011012122A (es) Derivados de tiofeno.
TN2009000249A1 (en) Mapk/erk kinase inhibitors
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
CO6400138A2 (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
UA94052C2 (uk) Похідні піридазину
TW200833324A (en) Sulfonamide derivatives
PE20120648A1 (es) Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
MX2007006284A (es) Acidos biariloximetilarenocarboxilicos.
MX2009005071A (es) Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.
UY30363A1 (es) Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
BRPI0607330A2 (pt) composto, processo para preparar o mesmo, composição farmacêutica, método para tratar inflamação ou prevenir apoptose em um indivìduo, e, uso do composto
MX2009004295A (es) Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
MX2009013003A (es) Derivados de piperidina-amida.
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
BRPI0606923A2 (pt) substáncia para uso como um medicamento, uso de uma substáncia, método de manufatura de uma substáncia para uso como um medicamento, formulação farmacêutica, e, método de manufatura de uma formulação farmacêutica
MX339727B (es) Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para estabilizar el compuesto.
TW200800993A (en) Organic compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal